IL6 and prostate cancer: To determine whether the link between ESE3/EHF and IL-6 observed in our cell line models was seen also in clinical samples, we analyzed gene expression data from two large (n = 545 and n = 131, respectively) human prostate cancer patients datasets [20, 21].